CTX120

· CRISPR Therapeutics AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CTX120, covering 2025-01-08 to 2025-01-08. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study Evaluating CTX120 in Subjects With Relapsed or Refractory Multiple Myeloma [Phase 1]